 |
adenovirus delta 24-RGD, an oncolytic adenovirus genetically modified for treatment of glioma |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2014-10-01 00:00:00 |
| Sponsor | DNAtrix, Inc.;3210 Merryfield Row;San Diego, California, 92121 |
Related Access Program